Options for medical treatment of myomas

被引：19

作者：

Rackow, BW ^{[1
]}

Arici, A ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2006年 / 33卷 / 01期

关键词：

D O I：

10.1016/j.ogc.2005.12.014

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Uterine myomas are a prevalent issue for women of reproductive age. For patients who desire future fertility or conservative management of myomas, medical therapies can be an effective management option. Estrogen and progesterone impact myoma growth and development, and current medical therapies manipulate these steroid hormones to affect myoma size and abnormal bleeding. Future therapies are likely to target more specific hormone regulation, growth factors, or gene regulation.

引用

页码：97 / +

页数：18

共 69 条

[31] MITOTIC-ACTIVITY IN UTERINE LEIOMYOMAS DURING THE MENSTRUAL-CYCLE [J].

KAWAGUCHI, K ;

FUJII, S ;

KONISHI, I ;

NANBU, Y ;

NONOGAKI, H ;

MORI, T .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (03) :637-641

[32]

Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1

[33] Hemodynamic effect of danazol therapy in women with uterine leiomyomata [J].

La Marca, A ;

Musacchio, MC ;

Morgante, G ;

Petraglia, F ;

De Leo, V .

FERTILITY AND STERILITY, 2003, 79 (05) :1240-1242

[34] Pirfenidone: A novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production [J].

Lee, BS ;

Margolin, SB ;

Nowak, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :219-223

[35] Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review [J].

Lethaby, A ;

Vollenhoven, B ;

Sowter, M .

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (10) :1097-1108

[36] Controversies and challenges in the modern management of uterine fibroids [J].

Manyonda, S ;

Sinthamoney, E ;

Belli, AM .

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (02) :95-102

[37] A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata [J].

Marshall, LM ;

Spiegelman, D ;

Goldman, MB ;

Manson, JE ;

Colditz, GA ;

Barbieri, RL ;

Stampfer, MJ ;

Hunter, DJ .

FERTILITY AND STERILITY, 1998, 70 (03) :432-439

[38] Effects of progesterone on growth factor expression in human uterine leiomyoma [J].

Maruo, T ;

Matsuo, H ;

Shimomura, Y ;

Kurachi, O ;

Gao, Z ;

Nakago, S ;

Yamada, T ;

Chen, W ;

Wang, JY .

STEROIDS, 2003, 68 (10-13) :817-824

[39]

MIXSON WT, 1961, AM J OBSTET GYNECOL, V82, P754

[40] REGRESSION OF UTERINE LEIOMYOMATA IN RESPONSE TO THE ANTIPROGESTERONE RU-486 [J].

MURPHY, AA ;

KETTEL, LM ;

MORALES, AJ ;

ROBERTS, VJ ;

YEN, SSC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) :513-517

← 1 2 3 4 5 6 7 →